Mouse Anti-AHNAK2 Recombinant Antibody (CBT3497) (V2LY-0625-LY2028)

Lin, Q. Y., Qi, Q. L., Hou, S., Chen, Z., Jiang, N., Zhang, L., & Lin, C. H. (2021). Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway. Neoplasma.

Zheng, M., Liu, J., Bian, T., Liu, L., Sun, H., Zhou, H., ... & Liu, Y. (2021). Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. International Immunopharmacology, 90, 107134.

Zheng, L., Li, S., Zheng, X., Guo, R., & Qu, W. (2021). AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis. International Immunopharmacology, 90, 107185.

Wang, D. W., Zheng, H. Z., Cha, N., Zhang, X. J., Zheng, M., Chen, M. M., & Tian, L. X. (2020). Down-regulation of AHNAK2 inhibits cell proliferation, migration and invasion through inactivating the MAPK pathway in lung adenocarcinoma. Technology in Cancer Research & Treatment, 19, 1533033820957006.

Zhang, S., Lu, Y., Qi, L., Wang, H., Wang, Z., & Cai, Z. (2020). AHNAK2 is associated with poor prognosis and cell migration in lung adenocarcinoma. BioMed Research International, 2020.

Xie, Z., Lun, Y., Li, X., He, Y., Wu, S., Wang, S., ... & Zhang, J. (2020). Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma. Aging (Albany NY), 12(18), 18163.

Li, M., Liu, Y., Meng, Y., & Zhu, Y. (2019). AHNAK nucleoprotein 2 performs a promoting role in the proliferation and migration of uveal melanoma cells. Cancer biotherapy & radiopharmaceuticals, 34(10), 626-633.

Lu, D., Wang, J., Shi, X., Yue, B., & Hao, J. (2017). AHNAK2 is a potential prognostic biomarker in patients with PDAC. Oncotarget, 8(19), 31775.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols